The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm2009 · 300 citations
2. 2A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases2011 · 177 citations
3. 3Role of RUNX1 in hematological malignancies2017 · 484 citations
4. 4Posttranslational modifications of RUNX1 as potential anticancer targets2014 · 67 citations
5. 5Somatic point mutations in <i>RUNX1/CBFA2/AML1</i> are common in high‐risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia2004 · 57 citations